Licurse score — renal ultrasound in AKI

Check each criterion that applies. Each positive finding adds one point (0–7). Risk group follows the published stratification used in secondary summaries: low (0–2 points, without high-risk override), medium (3 points), high (≥4 points or history of hydronephrosis). For hospitalized adults with acute kidney injury being considered for renal ultrasonography.

History of hydronephrosisPrior documented hydronephrosis. Also places the patient in the high-risk group when present, independent of the total count.Recurrent urinary tract infectionsHistory consistent with recurrent or relapsing UTIs in the record.Diagnosis consistent with urinary tract obstructionPresentation or working diagnosis suggesting obstructive uropathy (e.g. stone, mass, stricture) per chart.Non-Black raceDerived variable in the original cohort study (Arch Intern Med 2010). Use as documented in the source framework; local practice and equity considerations may differ.No exposure to nephrotoxic medicationsPoint when the patient was not exposed to nephrotoxic drugs in the relevant window (absence of exposure was associated with hydronephrosis in the model).No congestive heart failurePoint when CHF is absent (absence of CHF was associated with hydronephrosis in the model).AKI not primarily prerenalPoint when AKI is not attributed mainly to prerenal causes (i.e. absence of prerenal AKI pattern was associated with hydronephrosis in the model).

Disclaimer: The Licurse framework was developed in a single-center inpatient AKI cohort undergoing renal ultrasound. It estimates risk of hydronephrosis and is not a substitute for clinical judgment, nephrology or urology consultation, or urgent imaging when obstruction is suspected.

Licurse score — scoring guide

Overview

The Licurse framework stratifies hospitalized adults with acute kidney injury (AKI) who are undergoing or being considered for renal ultrasonography (RUS), with respect to likelihood of hydronephrosis and hydronephrosis requiring intervention. Reference: Licurse A et al., Arch Intern Med 2010;170(21):1900–1907. DOI 10.1001/archinternmed.2010.419.

Seven binary factors (each +1 if present)

Factor	When to count a point
Prior hydronephrosis	Documented history of hydronephrosis
Recurrent UTIs	Recurrent urinary tract infections
Obstructive diagnosis	Clinical diagnosis consistent with urinary tract obstruction
Race (derivation variable)	Non-Black race in the original cohort definition
Nephrotoxic exposure	Absence of exposure to nephrotoxic medications (point when not exposed)
Congestive heart failure	Absence of CHF (point when no CHF)
Prerenal AKI	Absence of prerenal AKI as the primary attribution (point when AKI is not mainly prerenal)

Total count range 0–7. Definitions follow chart abstraction in the primary publication; reproduce those operational rules when auditing or research.

Risk groups (common clinical stratification)

Group	Rule
Low	0–2 factors present, and no standalone high-risk override
Medium	Exactly 3 factors; without history-of-HN high-risk override
High	≥4 factors or history of hydronephrosis

The primary paper emphasized a low-risk subset with lower hydronephrosis yield versus a combined higher-risk remainder. The three-tier cut points (0–2 / 3 / ≥4) align with widely used secondary summaries; confirm against your institutional guideline if policies specify a binary split.

Intended use and limits

Developed in US inpatients with AKI who received renal ultrasound; excluded pregnancy, transplant, and very recent hydronephrosis.
Moderate sensitivity and limited specificity in external samples; many patients remain intermediate probability.
Includes race as a modeled variable from the derivation era—interpret and operationalize with institutional and ethical oversight.
Does not replace bedside assessment, point-of-care ultrasound protocols, or urgent urologic referral when indicated.

Licurse Score for Renal Ultrasound in Acute Kidney Injury

Among hospitalized adults with acute kidney injury (AKI), renal ultrasonography (RUS) is ordered frequently to evaluate for hydronephrosis and obstructive uropathy. In many health systems the test is applied broadly, yet the incremental value varies widely by pre-test probability. The framework commonly referred to as the Licurse score (from the primary risk-stratification analysis by Licurse and colleagues) was developed to separate inpatients with AKI into groups with markedly different observed yields of hydronephrosis and hydronephrosis requiring urologic intervention, using only seven binary clinical factors abstracted from the chart at the time of imaging triage.

Why risk stratification matters before renal ultrasound

AKI has multiple mechanisms—prerenal hypoperfusion, intrinsic renal disease, and postrenal obstruction among them. Obstruction amenable to drainage can be time-sensitive, so clinicians are appropriately cautious about missing it. At the same time, indiscriminate use of RUS in every AKI episode increases cost, throughput burden, incidental findings, and downstream testing without proportional benefit when hydronephrosis is rare. A structured estimate of obstruction risk supports shared decision-making about whether to proceed with formal RUS, how urgently to schedule it, and whether adjunct strategies (focused physical examination, bladder management, point-of-care imaging where available, or specialist input) should run in parallel rather than serially.

The Licurse model does not diagnose obstruction and does not replace clinical gestalt when the presentation is strongly suggestive of an obstructing process. It is best understood as a probability organizer: a concise checklist that reproduces, in routine practice, the associations observed between baseline characteristics and ultrasound findings in a large single-center cohort of adults who already underwent RUS for AKI evaluation.

Population and scope of the original framework

The derivation and validation work focused on adult inpatients with AKI who received renal ultrasound to evaluate elevated creatinine. Standard exclusions in that program of research included pregnancy, kidney transplant recipients, and patients with recently diagnosed hydronephrosis where imaging redundancy was expected. Before applying the checklist to a given patient, confirm that your scenario is reasonably aligned with that context: ward or ICU hospitalization, AKI as the clinical problem prompting ultrasound consideration, and absence of those exclusion categories when you wish to mirror published performance estimates.

The seven binary factors

Each factor is counted as present or absent according to chart-based definitions used in the original study. In this calculator, each positive factor contributes one point, for a summed range of 0 through 7. Several items reflect associations from multivariable modeling rather than pathophysiologic axioms; they should be applied as operational criteria consistent with how data were captured historically, not as moral or essentialized patient attributes.

History of hydronephrosis

Prior documented hydronephrosis identifies patients with known anatomic or functional predisposition to collecting system dilation. In many clinical summaries this item also anchors a high-risk stratum even when the raw count of other factors is modest, reflecting the clinical imperative not to undertriage recurrent or relapsing obstruction in someone with established disease.

Recurrent urinary tract infections

Recurrent or relapsing urinary infections overlap with structural abnormalities, stones, stasis, and prior instrumentation. As an epidemiologic marker in the model, recurrent UTI history raises the indexed probability that ultrasound will show hydronephrosis in the AKI episode under review.

Diagnosis consistent with urinary tract obstruction

This item captures the clinician’s working diagnosis when it aligns with obstructive uropathy—examples include suspected nephrolithiasis with colic, malignant obstruction, stricture disease, or other presentations where the chart explicitly frames obstruction as a leading hypothesis. It formalizes what bedside assessment often already conveys: when the story “sounds obstructive,” imaging yield tends to rise.

Race (derivation cohort variable)

The original analysis reported an association between non-Black race and higher odds of hydronephrosis in the studied population after adjustment. Race was recorded as a demographic field in administrative and clinical data from that era and center. Contemporary deployment of any score that encodes race requires institutional oversight, transparent documentation of why a variable is or is not used, and alignment with local equity policies. Some organizations may choose to calculate the remainder of the score while separately documenting alternative risk review pathways; the calculator’s educational materials should be read alongside those governance decisions.

Absence of nephrotoxic medication exposure

A point is assigned when the patient was not exposed to nephrotoxic medications in the relevant exposure window abstracted for the study. Intuitively, many clinicians anchor AKI on hemodynamics or drug injury when nephrotoxins are prominent; when such exposure is absent, chart reviewers more often pursued and confirmed alternative mechanisms—including obstruction—leading to this statistical association in the derivation dataset.

Absence of congestive heart failure

Similarly, a point is assigned when congestive heart failure is absent. Heart failure frequently contributes to cardiorenal syndromes and prerenal patterns; its absence shifts the conceptual differential toward non-cardiac explanations for AKI, which in the modeled cohort correlated with higher ultrasound detection of hydronephrosis.

Absence of prerenal acute kidney injury

A point is assigned when AKI is not attributed primarily to prerenal physiology in the chart abstraction. Prerenal AKI from hypovolemia or reduced effective arterial volume often responds to resuscitation and does not require ultrasound to establish the diagnosis. When prerenal features are not dominant, reviewers more often entertained and identified obstructive patterns on imaging in the original report’s framework.

Risk groups and how to interpret the total

After summing points, patients are commonly placed into low, medium, and high groups for teaching and bedside communication. A widely reproduced partition uses 0–2 factors for low risk, exactly 3 factors for medium risk, and 4 or more factors for high risk, with an additional rule that documented prior hydronephrosis places the patient in the high-risk group even if the numeric count alone would be lower. This hybrid rule mirrors how tertiary summaries translate the original low-versus-higher split into finer gradients for day-to-day triage conversations.

In the large validation sample described in the primary report, overall rates of hydronephrosis and of hydronephrosis requiring intervention were low in absolute terms but concentrated in higher-risk subsets. The low-risk stratum contained a substantial fraction of the cohort yet accounted for a minority of positive ultrasound diagnoses, supporting the idea that routine RUS in every low-probability encounter is often low yield. Conversely, in higher-risk strata, event rates rose enough that deferring imaging without a clear alternate explanation becomes harder to justify.

Performance characteristics in perspective

Discrimination metrics from external evaluations of this stratification approach have generally emphasized high sensitivity for hydronephrosis and for intervention-requiring hydronephrosis when treating broader multicenter cohorts. That property makes the score attractive as a safety-oriented screen: missing obstruction is uncommon when patients are classified as higher risk. The tradeoff is comparatively limited specificity: many patients without hydronephrosis still fall outside the lowest band, so the score cannot be read as a binary test that “rules in” obstruction. Instead, it modulates urgency and resource allocation while leaving definitive diagnosis to imaging, procedure, or specialist evaluation.

Integrating the score with bedside judgment

Practical use begins with confirming that AKI is present by your institutional definition and that ultrasound is being considered for the same clinical question studied in the derivation work. Clinicians should walk through each of the seven domains explicitly—especially the three “absence” criteria, which are easy to miscount if read hastily. Hydronephrosis history should trigger heightened concern even when the arithmetic total is small.

Low-risk classification does not eliminate obstruction; rare cases still occur. It instead supports a structured pause: verify volume status, review medications, repeat renal labs after targeted therapy when appropriate, and document why imaging might be deferred or delayed. Medium-risk patients occupy a genuine gray zone where serial assessment, urine microscopy, bladder scanning, or consultant input may add more value than immediate repetition of tests. High-risk patients merit timely RUS (or equivalent imaging pathway) and early urology or interventional radiology coordination when clinical findings align.

Limitations and settings where the framework fits poorly

Patients outside inpatient AKI populations (outpatient creatinine changes, postoperative oliguria without formal AKI, pediatrics) are not represented.
Transplant, pregnancy, and very recent hydronephrosis were excluded from the primary cohort design.
Center-specific imaging practices, sonographer skill, and reporting thresholds for hydronephrosis can shift observed yields even when clinical risk is unchanged.
Race as a modeled variable carries social and ethical complexity; local policy may alter how—or whether—that item is applied.
The score does not incorporate stone size, prostate volume, catheter status, or detailed cancer staging, all of which may dominate individual decisions.

Using this calculator on CalcMD

The interactive tool on this page encodes the seven checklist items, computes the 0–7 total, assigns low, medium, or high risk per the common partition described above, and notes when prior hydronephrosis upgrades the group. Results are educational aids for clinicians, trainees, and quality teams reviewing AKI imaging appropriateness. They must be interpreted in light of the individual patient’s trajectory, comorbidities, anticoagulation status, contrast risks for alternative modalities, and institutional pathways for urgent decompression when obstruction is suspected on clinical grounds alone.

CalcMD.

Licurse Score for Renal Ultrasound

In-depth guide to the Licurse framework: seven factors for hydronephrosis risk before renal ultrasound in inpatient AKI, risk bands, validation context, and how to combine the score with clinical judgment.